US › Healthcare

Alaunos Therapeutics Inc (TCRT)

US · Healthcare · Biotechnology

$1.90-0.26%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-1.0M

Profit YoY

+6.2%

EPS

$-0.55

EPS estimate

$0.00

Key statistics

Market cap

$4.6M

Forward P/E

18.5

P/B

3.56

Book value

$0.54

EPS (TTM)

$-2.12

52-week high

$4.59

52-week low

$1.67

50-day MA

$2.21

200-day MA

$2.82

Beta

-1.02

Analyst view

Analysts rate Alaunos Therapeutics Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $1.75.

Shareholding

Insiders

15.73%

Institutions

6.53%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.92%
BlackRock Inc	0.87%
Vanguard Fiduciary Trust Co	0.63%
Vanguard Capital Management, LLC	0.58%
HRT FINANCIAL LLC	0.55%
Two Sigma Investments LLC	0.44%
Citadel Advisors Llc	0.43%
XTX Topco Ltd	0.42%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alaunos Therapeutics Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.